
US-based biopharmaceutical company Dicerna Pharmaceuticals has closed their initial public offering selling 6.9 million shares of common stock.
Chinese mobile game developer Chukong Technologies is preparing a $150m US initial public offering.
Molecular oncology diagnostics company Biocept has raised $19m in their initial public offering by selling 1.9 million shares of common stock.
Alder, which is developing antibodies to fight migraine and arthritis, secured $38m in a 2012 venture round backed by Novo and TPG, and will use the money from the initial public offering to forward testing.
The aldehyde disease specialist, in which Johnson & Johnson owns a 44.5% stake, could potentially raise up to $27.6m from the initial public offering.
Kaiser Permanente-backed Agile plans to use the proceeds from its initial public offering to support clinical trials of its lead product candidate, a weekly contraceptive patch.
US-based cardiovascular drug developer Celladon has raised $50.6m in their initial public offering selling 6.325 million shares at $8 each.
Weibo has become the latest Chinese company to tap the US public markets, targeting $500 million from its initial public offering, and plans to leverage its partnership with minority shareholder Alibaba to maxmise advertising revenue.
Cleveland Clinic-backed healthcare services analytics provider Castlight Health has closed a $204.24m initial public offering